- DE ANGELIS M, Gori Savellini G, Piselli E, Anichini G, et al
Redox-sensitive factors as targets of thiol compounds to hinder SARS-CoV-2 replication and inflammatory response.
Antimicrob Agents Chemother. 2026;70:e0051826.
PubMed Abstract available - JEENA N, Khan IA
Targeting SARS-CoV-2 programmed -1 ribosomal frameshifting: structural dynamics and RNA-directed antiviral strategies.
Antimicrob Agents Chemother. 2026;70:e0068726.
PubMed Abstract available - AVILA-PONCE DE LEON U, Esmaeili S, Owens K, Schiffer JT, et al
Plasma concentrations of nirmatrelvir and molnupiravir required for inhibition of SARS-CoV-2 replication differ between rhesus macaques and humans.
Antimicrob Agents Chemother. 2026 Aug 5:e0030726. doi: 10.1128/aac.00307.
PubMed Abstract available - PU F, Guo Y, Pan X, Liu X, et al
Dual-targeting engineered binding proteins block SARS-CoV-2 infection and complement activation.
Antiviral Res. 2026;254:106515.
PubMed Abstract available - YURGELONIS I, Rai DK, Lee JT, Li Z, et al
Antiviral activity of nirmatrelvir against contemporary SARS-CoV-2 variants.
Antiviral Res. 2026;254:106517.
PubMed Abstract available - NAQVI OH, Wendelboe AM, Beasley WH, Tyungu DL, et al
Epidemiological characteristics of paediatric COVID-19 and influenza co-infections in the United States, 2020-2024 - CORRIGENDUM.
Epidemiol Infect. 2026;154:e111.
PubMed - ZHAO B, Zhang G, Wu J, Zhang W, et al
Characterization of bronchiolitis and vaccine-induced enhanced respiratory disease in Syrian hamsters caused by respiratory syncytial virus infection.
J Infect Dis. 2026 Mar 4:jiag136. doi: 10.1093.
PubMed Abstract available - BHAVSAR D, Civljak A, Bonnettaz B, Arunkumar GA, et al
Broadly reactive antibodies against influenza B virus hemagglutinin neutralize and protect through distinct structural mechanisms.
J Virol. 2026 Sep 4:e0080226. doi: 10.1128/jvi.00802.
PubMed Abstract available - LIU D, Zhang Y, Zhang M, Guo R, et al
A neuraminidase-targeting nanobody as a therapeutic candidate against influenza A and B viruses.
J Virol. 2026 Aug 31:e0087426. doi: 10.1128/jvi.00874.
PubMed Abstract available - SENERTH E, Sheikholeslamian SM, Sivakumaran K, Watson MA, et al
Influenza Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season.
JAMA. 2026 Sep 2. doi: 10.1001/jama.2026.18126.
PubMed Abstract available - CHAN OW, Cheng YT, Liu YH, Chou IJ, et al
Anakinra in Severe RSV-Associated Autoinflammatory Encephalopathy With Delayed ADEM-Like Changes.
Pediatrics. 2026;158:e2026076364.
PubMed Abstract available - PAYNE AB, Battan-Wraith S, Reese SE, Hathaway CA, et al
Effectiveness of RSV Prevention Strategies in US Infants: 2024-2025.
Pediatrics. 2026 Aug 4:e2026076089. doi: 10.1542/peds.2026-076089.
PubMed Abstract available - MIN J, Tam V, Jacoby SF, McDonald CC, et al
Community Firearm Violence, Youth Depression, and Suicide Risk in Philadelphia: 2017-2024.
Pediatrics. 2026;158:e2025075438.
PubMed Abstract available - FREEDMAN AS, Nielsen BF, Saad-Roy CM, Grenfell BT, et al
Economic factors promoting vaccine nationalism in the face of viral evolution.
PLoS Comput Biol. 2026;22:e1014466.
PubMed Abstract available - ELIAS KM, Mitchell A, Stadler E, Schlub TE, et al
Neutralising antibodies and protection from progression to severe COVID-19: A meta-analysis.
PLoS Med. 2026;23:e1005230.
PubMed Abstract available - ADAMCZYK G, Jablonski A, Nowakowski PT, Ptaszek RT, et al
Theodicy perspective as an effect of the interpenetration of mental and religious issues during the COVID-19 pandemic in Poland.
PLoS One. 2026;21:e0355379.
PubMed Abstract available - JUNGMANN SM, Garbe Huedo SF, Jacobs KAS, Pothorn NK, et al
Mental load in women and mothers: Causes of distress, personality traits, and psychopathology.
PLoS One. 2026;21:e0356255.
PubMed Abstract available - MOUNADI N, Nour H, El Kouali M, Samadi A, et al
Repositioning antiviral phytoconstituents as broad-spectrum inhibitors of influenza A neuraminidase and human metapneumovirus fusion protein.
PLoS One. 2026;21:e0348517.
PubMed Abstract available - HAWKES BA, Hollister J, Porter C, Lyski ZL, et al
Age-specific humoral immune response to SARS-CoV-2: A comparative analysis of antibody levels in children and adults after vaccination with primary series or infection.
PLoS One. 2026;21:e0356178.
PubMed Abstract available - AVSAR FN, Kilicaslan N, Sahutoglu T
Comparative associations of Anakinra and Tocilizumab initiation with in-hospital mortality in severe COVID-19: A single-center sequential cohort study.
PLoS One. 2026;21:e0357671.
PubMed Abstract available - SEEGERT N, Gaulin M, Chaiyakunapruk N, Navarro-Sanchez F, et al
The impact of state- versus county-level mask mandates on economic activity during the COVID-19 pandemic.
PLoS One. 2026;21:e0332243.
PubMed Abstract available - HARDY MJ, Williams CK, Ladman BS, Pitesky ME, et al
Using high frequency GPS data to assess wintering goose proximity to commercial poultry facilities on the Delmarva peninsula for avian influenza risk management and surveillance.
PLoS One. 2026;21:e0355415.
PubMed Abstract available - KOPP J, Spies Rodriguez DC, Kunzi L, Puhan MA, et al
Physical activity in post-COVID-19 condition: A cross-sectional study.
PLoS One. 2026;21:e0357465.
PubMed Abstract available - KARADAKIC R, Keating NL, Barnett ML
Interpreting vaccine-associated survival differences in immune checkpoint inhibitor therapy.
Proc Natl Acad Sci U S A. 2026;123:e2621501123.
PubMed Abstract available - MOHAMMED H, Andraweera P, Marshall HS
A cohort study to assess the safety and coverage of COVID-19, influenza, and pertussis vaccine in Australian pregnant women.
Vaccine. 2026;91:129081.
PubMed Abstract available - SHEN AK, Tupps C, Bino S, Chipoya M, et al
Investments in seasonal influenza vaccination programs pack a punch for pandemic preparedness.
Vaccine. 2026;92:129098.
PubMed Abstract available - TRAN S, McClymont E, Blitz S, Barrett J, et al
Self-reported reactogenicity after COVID-19 vaccination with and without influenza vaccine coadministration during pregnancy in Canada.
Vaccine. 2026;92:129122.
PubMed Abstract available - MARIA DA, Martins IM, Porto GPM, Villas-Boas IM, et al
Safety, humoral and cellular immune responses to a pre-pandemic adjuvanted influenza A (H5N8) vaccine.
Vaccine. 2026;92:129049.
PubMed Abstract available - ZHENG Y, Qiao B, Gao Z, Zhang X, et al
Development of a subunit vaccine candidate (RBD-HA trimer) provides dual protection against multi-subtype avian influenza viruses and QX-type infectious bronchitis virus.
Vaccine. 2026;92:129121.
PubMed Abstract available - KORNUTA CA, Zhou G, Kane KP, Vliagoftis H, et al
Mucosal adjuvant activity of a PAR-2-activating peptide enhances lymph node immune cell recruitment and promotes immune cell activation in a prime-boost influenza vaccination model.
Vaccine. 2026;92:129110.
PubMed Abstract available - BROGAARD L, Laybourn HA, Kristensen C, Welner S, et al
Site-specific microRNA responses in lungs of pigs depend on the host-adaptation of H1N1 influenza A virus.
Virology. 2026;624:111053.
PubMed Abstract available - SEKINE W, Kamiki H, Ishida H, Matsugo H, et al
HA1-T138A and HA1-Q226L substitutions in H3N2 canine influenza virus contribute to binding to human-type alpha2,6-linked sialic acid receptors.
Virology. 2026;625:111071.
PubMed Abstract available - OLDENSAND F, Rafati N, Van Hoef V, Lundkvist A, et al
Single-cell transcriptomic landscape of avian influenza H9N2 virus infection in human and chicken cells.
Virology. 2026;625:111070.
PubMed Abstract available
Antimicrob Agents Chemother
No comments:
Post a Comment